Wealth Enhancement Advisory Services LLC Has $70,000 Stake in Tilray Inc (NASDAQ:TLRY)

Wealth Enhancement Advisory Services LLC increased its holdings in shares of Tilray Inc (NASDAQ:TLRY) by 22.6% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 39,819 shares of the company’s stock after acquiring an additional 7,339 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Tilray were worth $70,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. HBK Sorce Advisory LLC acquired a new stake in shares of Tilray during the 1st quarter valued at about $37,000. Prospect Financial Services LLC acquired a new stake in shares of Tilray during the 2nd quarter valued at about $26,000. Signature Estate & Investment Advisors LLC acquired a new stake in shares of Tilray during the 2nd quarter valued at about $29,000. Jeppson Wealth Management LLC acquired a new stake in shares of Tilray during the 2nd quarter valued at about $33,000. Finally, Pallas Capital Advisors LLC acquired a new position in Tilray in the second quarter valued at about $37,000. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Roth Mkm reduced their price target on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research report on Friday, October 11th.

Tilray Trading Down 2.0 %

Shares of NASDAQ TLRY opened at $1.44 on Thursday. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The company has a market cap of $1.30 billion, a PE ratio of -5.33 and a beta of 2.14. The company has a 50-day moving average of $1.66 and a two-hundred day moving average of $1.78. Tilray Inc has a 1-year low of $1.36 and a 1-year high of $2.97.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.04). The business had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. Tilray’s revenue for the quarter was up 13.0% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.10) earnings per share. As a group, equities analysts expect that Tilray Inc will post -0.14 earnings per share for the current fiscal year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.